Literature DB >> 20222852

Identification of bioactive natural products by pharmacophore-based virtual screening.

Daniela Schuster1, Gerhard Wolber.   

Abstract

Natural products have been exposed to a long selection process to interact with biological targets and are therefore a valuable source for ideas for novel chemical entities in drug development. However, the process to determine activities of natural products is mainly based on serendipity, and can thus become time- and cost-intensive. In this review we present strategies on how modern in-silico molecular modeling techniques can be used to make this process more efficient and discuss how to discover and optimize drug candidates inspired by nature. Focusing on 3D pharmacophore modeling techniques, we provide an overview of virtual screening and modeling methods, review available in silico databases as sources for chemical structures of natural products, discuss techniques for biological activity profiling, and summarize recent success stories for the combination of in-silico approaches and pharmacognosy.

Mesh:

Substances:

Year:  2010        PMID: 20222852     DOI: 10.2174/138161210791164072

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Evaluation of anti-resistant activity of Auklandia (Saussurea lappa) root against some human pathogens.

Authors:  Sidgi Syed Anwer Hasson; Mohammed Saeed Al-Balushi; Khazina Alharthy; Juma Zaid Al-Busaidi; Muna Suliman Aldaihani; Mohammed Shafeeq Othman; Elias Antony Said; Omar Habal; Talal Abdullah Sallam; Ali Abdullah Aljabri; Mohamed Ahmedidris
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

Review 3.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

4.  A database for the predicted pharmacophoric features of medicinal compounds.

Authors:  Pitchai Daisy; Sanjeev Kumar Singh; Periyasamy Vijayalakshmi; Chandrabose Selvaraj; Manikkam Rajalakshmi; Sukumaran Suveena
Journal:  Bioinformation       Date:  2011-05-07

5.  Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.

Authors:  Jie Xia; Ermias Lemma Tilahun; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  Methods       Date:  2014-12-03       Impact factor: 3.608

6.  Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.

Authors:  Jie Xia; Terry-Elinor Reid; Song Wu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

7.  Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine.

Authors:  Birgit Waltenberger; Daniela Schuster; Sompol Paramapojn; Wandee Gritsanapan; Gerhard Wolber; Judith M Rollinger; Hermann Stuppner
Journal:  Phytomedicine       Date:  2010-09-20       Impact factor: 5.340

8.  Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation.

Authors:  Daniela Schuster; Patrick Markt; Ulrike Grienke; Judit Mihaly-Bison; Markus Binder; Stefan M Noha; Judith M Rollinger; Hermann Stuppner; Valery N Bochkov; Gerhard Wolber
Journal:  Bioorg Med Chem       Date:  2011-10-04       Impact factor: 3.641

9.  Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation.

Authors:  Laura Guasch; Esther Sala; Anna Castell-Auví; Lidia Cedó; Klaus R Liedl; Gerhard Wolber; Markus Muehlbacher; Miquel Mulero; Montserrat Pinent; Anna Ardévol; Cristina Valls; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity.

Authors:  Laura Guasch; Esther Sala; Miquel Mulero; Cristina Valls; Maria Josepa Salvadó; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.